Honda, Y., Imajo, K., Kato, T., Kessoku, T., Ogawa, Y., Tomeno, W., . . . Nakajima, A. (2016). The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in Mice. PLoS One.
Čikaški stil citiranjaHonda, Yasushi, et al. "The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect On Nonalcoholic Steatohepatitis in Mice." PLoS One 2016.
MLA način citiranjaHonda, Yasushi, et al. "The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect On Nonalcoholic Steatohepatitis in Mice." PLoS One 2016.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.